COVID-19 FDA Governance Pharmaceutical Industry 
Bill of Health
SEPTEMBER 12, 2023
By James René Jolin and Susannah Baruch On July 13, 2023, the United States Food and Drug Administration (FDA) approved Opill (norgestrel) as the first daily oral contraceptive available for non-prescription use in the U.S. James René Jolin (JRJ): This recent move by the FDA is one without precedent. It was a long time coming.
Bill of Health
SEPTEMBER 28, 2023
By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SQA
AUGUST 2, 2021
COVID-19 Response: Freely Available ISO Standards, 18 June 2021. A number of ISO standards have been made available to support global efforts to address the COVID-19 crisis. Led by the FDA and ASPR, the White House report and its recommendations ( report PDF ) have been accepted by President Biden. b) and 320.31(d)(3)).
SQA
FEBRUARY 26, 2024
This standard is a globally recognized standard that provides guidelines for the governance and management of AI technologies. It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines.
Hall Render
APRIL 21, 2023
health-tech startup MemoryWell pivots, eyes new funding to roll out software for insurers Department of Veterans Affairs health system kicks off multiyear Greater Washington expansion Georgetown to open Southeast D.C.
Expert insights. Personalized for you.
184 
Let's personalize your content